📰 Program On Medicare News
Program On Medicare News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Program On Medicare. Real-time updates on events, politics, business and more.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
April 24, 2024
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.